LXEO vs ZION · $147.7M cap vs P/E 11, rev $354.0M
Lexeo Therapeutics, Inc. Common Stock (LXEO) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
LXEO does not have a complete income-statement cache yet.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
LXEO currently screens at market cap $147.7M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the LXEO and ZION stock pages for the full models.
Not investment advice.